NRx Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.03-$0.39 |
Market Cap | $714.6M |
Shares Short | 1,468 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$6.24 |
About
CEO | Dr. Jonathan C. Javitt M.D., M.P.H. |
CFO | Mr. Richard Clavano Narido |
Address | 1201 Orange Street, Wilmington, DE, United States, 19801 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
